Pain News and Research

Latest Pain News and Research

Survey: 2.5 million people experience back pain every day in the UK

One in five people who suffer from back pain have given up their job or reduced their hours because of their condition.

From medserena 9 Oct 2018

CoreChoice and MINES partner to form PPO network to combat opioid and substance use

CoreChoice, the national specialty network for radiology, interventional pain management, and medical air transportation services is pleased to announce their partnership agreement with MINES & Associates to form the nation's first PPO network solution to combat the nationwide opioid and polysubstance use epidemic.

8 Oct 2018

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.

8 Oct 2018

Medicare Advantage plans shift their financial risk to doctors

Dr. Christopher Rao jumped out of his office chair. He'd just learned an elderly patient at high risk of falling was resisting his advice to go to an inpatient rehabilitation facility following a hip fracture.

8 Oct 2018

Damage to small nerves shown to be cause of chronic pain following knee surgeries

Patients frequently experience severe chronic pain following knee operations. Although the pain is thought to be due to damage to small nerves, it was hitherto impossible to demonstrate this by imaging.

8 Oct 2018

T-CALM Phase 2 clinical study results offer hope for essential tremor patients

Cavion, Inc., a leading clinical stage biotechnology company committed to developing novel therapeutics for people with neurological diseases, today announced promising results of the T-CALM Phase 2 clinical trial of its first-in-class T-type calcium channel modulator CX-8998 in essential tremor.

7 Oct 2018

Health insurers have inconsistent policy terms for non-drug pain treatments, study finds

Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating lower back pain, a study led by researchers at Johns Hopkins Bloomberg School of Public Health has found.

6 Oct 2018

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.

6 Oct 2018

Krembil scientists develop potential treatment to stop knee and spine osteoarthritis

Scientists at the Krembil Research Institute have developed a novel therapeutic treatment that has the potential to stop knee and spine osteoarthritis in its tracks.

5 Oct 2018

Congress targets misuse of hospice drugs

Hospice workers would be allowed to destroy patients’ unneeded opioids, reducing the risk that families misuse them, according to one little-noticed provision in the bipartisan opioids bill headed to President Donald Trump’s desk for his likely signature.

5 Oct 2018

Pilot study shows how migraine can be treated without medicine

By slightly changing the body's own molecules using a small inhaler, certain migraine patients can either cut down on medication or do without it completely. This is shown by a pilot study which has been published in the scientific journal Cephalalgia.

4 Oct 2018

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting glycolate oxidase for the treatment of primary hyperoxaluria type 1.

4 Oct 2018

Viruses shown to cause bowel dysfunction and abdominal pain

Viruses known to target the central nervous system may also affect neurons of the digestive tract, causing bowel dysfunction and abdominal pain.

4 Oct 2018

Human clinical trial of investigational calcification inhibitor generates promising results

Cardiovascular calcification is a major health concern in patients with kidney failure undergoing hemodialysis.

3 Oct 2018

CBT for insomnia may slow or reverse cortical atrophy in patients with co-morbid fibromyalgia

Preliminary findings from a pilot study suggest that cognitive behavioral therapy for insomnia may slow or even reverse the atrophy of cortical gray matter in patients who have co-morbid fibromyalgia.

3 Oct 2018

Study finds disease-causing mutation in French-Canadians

A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson's disease, dementia with Lewy-Bodies and multiple system atrophy

1 Oct 2018

VR found to be effective in reducing perceived pain during exercise

The research, led by PhD candidate Maria Matsangidou from EDA, set out to determine how using VR while exercising could affect performance by measuring a raft of criteria: heart rate, including pain intensity, perceived exhaustion, time to exhaustion and private body consciousness.

1 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

MTF Biologics introduces Flexhd Pliable PRE for pre-pectoral breast reconstruction

MTF Biologics is expanding its portfolio of innovations for post-mastectomy breast reconstruction with the launch of an acellular dermal matrix designed specifically for pre-pectoral breast reconstruction procedures: FlexHD Pliable PRE.

1 Oct 2018

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the disease who do not respond to conventional treatment.

29 Sep 2018

Pain News and Research

Latest Pain News and Research

Survey: 2.5 million people experience back pain every day in the UK

CoreChoice and MINES partner to form PPO network to combat opioid and substance use

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Medicare Advantage plans shift their financial risk to doctors

Damage to small nerves shown to be cause of chronic pain following knee surgeries

T-CALM Phase 2 clinical study results offer hope for essential tremor patients

Health insurers have inconsistent policy terms for non-drug pain treatments, study finds

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

Krembil scientists develop potential treatment to stop knee and spine osteoarthritis

Congress targets misuse of hospice drugs

Pilot study shows how migraine can be treated without medicine

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Viruses shown to cause bowel dysfunction and abdominal pain

Human clinical trial of investigational calcification inhibitor generates promising results

CBT for insomnia may slow or reverse cortical atrophy in patients with co-morbid fibromyalgia

Study finds disease-causing mutation in French-Canadians

VR found to be effective in reducing perceived pain during exercise

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

MTF Biologics introduces Flexhd Pliable PRE for pre-pectoral breast reconstruction

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

Innovation in neuroscience drug discovery - eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Pain News and Research

Latest Pain News and Research

Innovation in neuroscience drug discovery - eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in